{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T13:22:11Z","timestamp":1758979331254,"version":"3.44.0"},"reference-count":82,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience &amp; Biobehavioral Reviews"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.neubiorev.2022.104910","type":"journal-article","created":{"date-parts":[[2022,10,11]],"date-time":"2022-10-11T04:20:09Z","timestamp":1665462009000},"page":"104910","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["The boundlessness of behavioral neuroscience: A look across 30 years"],"prefix":"10.1016","volume":"142","author":[{"given":"K.B.","family":"Bjugstad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.R.","family":"Sanberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.neubiorev.2022.104910_bib1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0090953","article-title":"Combination therapy of human umbilical cord blood cells and granulocyte colony stimulating factor reduces histopathological and motor impairments in an experimental model of chronic traumatic brain injury","volume":"9","author":"Acosta","year":"2014","journal-title":"PLoS One"},{"issue":"19","key":"10.1016\/j.neubiorev.2022.104910_bib2","doi-asserted-by":"crossref","first-page":"8155","DOI":"10.1073\/pnas.0702698104","article-title":"Long-term effects of chronic nicotine exposure on brain nicotinic receptors","volume":"104","author":"Besson","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"7 Pt 2","key":"10.1016\/j.neubiorev.2022.104910_bib3","doi-asserted-by":"crossref","first-page":"5372","DOI":"10.1523\/JNEUROSCI.15-07-05372.1995","article-title":"Elevated body swing test: a new behavioral parameter for rats with 6-hydroxydopamine-induced hemiparkinsonism","volume":"15","author":"Borlongan","year":"1995","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.neubiorev.2022.104910_bib4","first-page":"15","article-title":"Asymmetrical behavior in rats following striatal lesions and fetal transplants: the elevated body swing test","volume":"9","author":"Borlongan","year":"1995","journal-title":"Restor. Neurol. Neurosci."},{"issue":"1","key":"10.1016\/j.neubiorev.2022.104910_bib5","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0006-8993(95)00150-O","article-title":"Asymmetrical motor behavior in rats with unilateral striatal excitotoxic lesions as revealed by the elevated body swing test","volume":"676","author":"Borlongan","year":"1995","journal-title":"Brain Res."},{"issue":"4","key":"10.1016\/j.neubiorev.2022.104910_bib6","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1080\/01616412.1996.11740425","article-title":"CNS immunological modulation of neural graft rejection and survival","volume":"18","author":"Borlongan","year":"1996","journal-title":"Neurol. Res."},{"key":"10.1016\/j.neubiorev.2022.104910_bib7","first-page":"1","article-title":"The elevated body swing test (EBST): a measure of motor behavior asymmetry in animals with unilateral CNS lesions","volume":"10","author":"Borlongan","year":"1996","journal-title":"Neurosci. Protoc."},{"issue":"1","key":"10.1016\/j.neubiorev.2022.104910_bib8","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1006\/exnr.1997.6513","article-title":"Intracerebral transplantation of testis-derived sertoli cells promotes functional recovery in female rats with 6-hydroxydopamine-induced hemiparkinsonism","volume":"148","author":"Borlongan","year":"1997","journal-title":"Exp. Neurol."},{"issue":"3","key":"10.1016\/j.neubiorev.2022.104910_bib9","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S1385-299X(96)00037-2","article-title":"Hyperactivity and hypoactivity in a rat model of Huntington's disease: the systemic 3-nitropropionic acid model","volume":"1","author":"Borlongan","year":"1997","journal-title":"Brain Res. Brain Res. Protoc."},{"key":"10.1016\/j.neubiorev.2022.104910_bib10","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3758\/BF03330590","article-title":"Effects of fetal striatal transplants on motor asymmetry in ibotenic acid model of Huntington\u2019s disease","volume":"26","author":"Borlongan","year":"1998","journal-title":"Psychobiology"},{"issue":"12","key":"10.1016\/j.neubiorev.2022.104910_bib11","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1097\/00001756-199808240-00028","article-title":"Viability and survival of hNT neurons determine degree of functional recovery in grafted ischemic rats","volume":"9","author":"Borlongan","year":"1998","journal-title":"Neuroreport"},{"issue":"2","key":"10.1016\/j.neubiorev.2022.104910_bib12","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1177\/096368979800700208","article-title":"Bilateral fetal striatal grafts in the 3-nitropropionic acid-induced hypoactive model of Huntington's disease","volume":"7","author":"Borlongan","year":"1998","journal-title":"Cell Transpl."},{"issue":"2","key":"10.1016\/j.neubiorev.2022.104910_bib13","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1006\/exnr.1997.6730","article-title":"Transplantation of cryopreserved human embryonal carcinoma-derived neurons (NT2N cells) promotes functional recovery in ischemic rats","volume":"149","author":"Borlongan","year":"1998","journal-title":"Exp. Neurol."},{"issue":"2","key":"10.1016\/j.neubiorev.2022.104910_bib14","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0166-4328(86)90012-4","article-title":"The topography of the locomotor effects of haloperidol and domperidone","volume":"19","author":"Bunsey","year":"1986","journal-title":"Behav. Brain Res."},{"issue":"11","key":"10.1016\/j.neubiorev.2022.104910_bib15","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1161\/hs1101.098367","article-title":"Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats","volume":"32","author":"Chen","year":"2001","journal-title":"Stroke"},{"issue":"3","key":"10.1016\/j.neubiorev.2022.104910_bib16","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1089\/scd.2012.0345","article-title":"Multiple low-dose infusions of human umbilical cord blood cells improve cognitive impairments and reduce amyloid-beta-associated neuropathology in Alzheimer mice","volume":"22","author":"Darlington","year":"2013","journal-title":"Stem Cells Dev."},{"issue":"4","key":"10.1016\/j.neubiorev.2022.104910_bib17","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/0091-3057(91)90256-2","article-title":"Nicotine potentiates haloperidol-induced catalepsy and locomotor hypoactivity","volume":"38","author":"Emerich","year":"1991","journal-title":"Pharm. Biochem. Behav."},{"issue":"5","key":"10.1016\/j.neubiorev.2022.104910_bib18","doi-asserted-by":"crossref","first-page":"963","DOI":"10.3727\/096368915X688579","article-title":"Plasma derived from human umbilical cord blood modulates mitogen-induced proliferation of mononuclear cells isolated from the peripheral blood of ALS patients","volume":"25","author":"Eve","year":"2016","journal-title":"Cell Transpl."},{"key":"10.1016\/j.neubiorev.2022.104910_bib19","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.neubiorev.2021.11.039","article-title":"The prevalence, odds, predictors, and management of tobacco use disorder or nicotine dependence among people with severe mental illness: systematic review and meta-analysis","volume":"132","author":"Fornaro","year":"2022","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"22","key":"10.1016\/j.neubiorev.2022.104910_bib20","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1056\/NEJM199211263272202","article-title":"Survival of implanted fetal dopamine cells and neurologic improvement 12\u201346 months after transplantation for Parkinson's disease","volume":"327","author":"Freed","year":"1992","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.neubiorev.2022.104910_bib21","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/ana.410380307","article-title":"Bilateral fetal nigral transplantation into the postcommissural putamen in Parkinson's disease","volume":"38","author":"Freeman","year":"1995","journal-title":"Ann. Neurol."},{"issue":"4","key":"10.1016\/j.neubiorev.2022.104910_bib22","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1080\/14660820152882179","article-title":"Intraspinal implantation of hNT neurons into SOD1 mice with apparent motor deficit","volume":"2","author":"Garbuzova-Davis","year":"2001","journal-title":"Amyotroph. Lateral Scler. Other Mot. Neuron Disord."},{"issue":"4","key":"10.1016\/j.neubiorev.2022.104910_bib23","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1089\/scd.2005.14.384","article-title":"Transplantation of human umbilical cord blood cells benefits an animal model of Sanfilippo syndrome type B","volume":"14","author":"Garbuzova-Davis","year":"2005","journal-title":"Stem Cells Dev."},{"issue":"2","key":"10.1016\/j.neubiorev.2022.104910_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0031254","article-title":"Multiple intravenous administrations of human umbilical cord blood cells benefit in a mouse model of ALS","volume":"7","author":"Garbuzova-Davis","year":"2012","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.neubiorev.2022.104910_bib25","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1080\/14712598.2017.1323862","article-title":"Cord blood as a potential therapeutic for amyotrophic lateral sclerosis","volume":"17","author":"Garbuzova-Davis","year":"2017","journal-title":"Expert Opin. Biol. Ther."},{"issue":"3","key":"10.1016\/j.neubiorev.2022.104910_bib26","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/JCP.0b013e318172b49e","article-title":"Nicotinic antagonist augmentation of selective serotonin reuptake inhibitor-refractory major depressive disorder: a preliminary study","volume":"28","author":"George","year":"2008","journal-title":"J. Clin. Psychopharmacol."},{"issue":"5","key":"10.1016\/j.neubiorev.2022.104910_bib27","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1212\/WNL.58.5.687","article-title":"Bilateral human fetal striatal transplantation in Huntington's disease","volume":"58","author":"Hauser","year":"2002","journal-title":"Neurology"},{"issue":"5\u20136","key":"10.1016\/j.neubiorev.2022.104910_bib28","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1399-5618.2011.00943.x","article-title":"The co-occurrence of cigarette smoking and bipolar disorder: phenomenology and treatment considerations","volume":"13","author":"Heffner","year":"2011","journal-title":"Bipolar Disord."},{"issue":"8","key":"10.1016\/j.neubiorev.2022.104910_bib29","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.3727\/096368916X691277","article-title":"Amelioration of ischemic brain injury in rats with human umbilical cord blood stem cells: mechanisms of action","volume":"25","author":"Hocum Stone","year":"2016","journal-title":"Cell Transpl."},{"issue":"1","key":"10.1016\/j.neubiorev.2022.104910_bib30","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s13195-021-00897-2","article-title":"Intracerebroventricular injection of human umbilical cord blood mesenchymal stem cells in patients with Alzheimer's disease dementia: a phase I clinical trial","volume":"13","author":"Kim","year":"2021","journal-title":"Alzheimers Res. Ther."},{"issue":"17","key":"10.1016\/j.neubiorev.2022.104910_bib31","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1056\/NEJM199504273321702","article-title":"Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease","volume":"332","author":"Kordower","year":"1995","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.neubiorev.2022.104910_bib32","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/sctm.18-0008","article-title":"Allogeneic umbilical cord blood infusion for adults with ischemic stroke: clinical outcomes from a phase I safety study","volume":"7","author":"Laskowitz","year":"2018","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.neubiorev.2022.104910_bib33","doi-asserted-by":"crossref","DOI":"10.1177\/09636897211067447","article-title":"Complete restoration of motor function in acute cerebral stroke treated with allogeneic human umbilical cord blood monocytes: preliminary results of a phase I clinical trial","volume":"30","author":"Lee","year":"2021","journal-title":"Cell Transpl."},{"issue":"8","key":"10.1016\/j.neubiorev.2022.104910_bib34","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1021\/cn100070s","article-title":"S)-(+)-mecamylamine (TC-5214): a neuronal nicotinic receptor modulator enters phase III trials as an adjunct treatment for Major Depressive Disorder (MDD)","volume":"1","author":"Lindsley","year":"2010","journal-title":"ACS Chem. Neurosci."},{"issue":"3","key":"10.1016\/j.neubiorev.2022.104910_bib35","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3727\/096020198389924","article-title":"Intravenous administration of human umbilical cord blood reduces neurological deficit in the rat after traumatic brain injury","volume":"11","author":"Lu","year":"2002","journal-title":"Cell Transpl."},{"issue":"6","key":"10.1016\/j.neubiorev.2022.104910_bib36","first-page":"793","article-title":"Nicotine potentiation of haloperidol in reducing tic frequency in Tourette's disorder","volume":"148","author":"McConville","year":"1991","journal-title":"Am. J. Psychiatry"},{"issue":"8","key":"10.1016\/j.neubiorev.2022.104910_bib37","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/0006-3223(92)90315-Q","article-title":"The effects of nicotine plus haloperidol compared to nicotine only and placebo nicotine only in reducing tic severity and frequency in Tourette's disorder","volume":"31","author":"McConville","year":"1992","journal-title":"Biol. Psychiatry"},{"issue":"7","key":"10.1016\/j.neubiorev.2022.104910_bib38","doi-asserted-by":"crossref","first-page":"483","DOI":"10.3109\/15622975.2014.989261","article-title":"Two Phase III randomised double-blind studies of fixed-dose TC-5214 (dexmecamylamine) adjunct to ongoing antidepressant therapy in patients with major depressive disorder and an inadequate response to prior antidepressant therapy","volume":"16","author":"Moller","year":"2015","journal-title":"World J. Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.neubiorev.2022.104910_bib39","first-page":"47","article-title":"Hypertension management: an update","volume":"3","author":"Nguyen","year":"2010","journal-title":"Am. Health Drug Benefits"},{"issue":"3","key":"10.1016\/j.neubiorev.2022.104910_bib40","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1089\/scd.2008.0018","article-title":"Peripherally administered human umbilical cord blood cells reduce parenchymal and vascular beta-amyloid deposits in Alzheimer mice","volume":"17","author":"Nikolic","year":"2008","journal-title":"Stem Cells Dev."},{"issue":"9","key":"10.1016\/j.neubiorev.2022.104910_bib41","doi-asserted-by":"crossref","first-page":"985","DOI":"10.3727\/096368909X471279","article-title":"Human umbilical cord blood cell grafts for brain ischemia","volume":"18","author":"Park","year":"2009","journal-title":"Cell Transpl."},{"issue":"1","key":"10.1016\/j.neubiorev.2022.104910_bib42","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/add.13943","article-title":"Mecamylamine treatment for alcohol dependence: a randomized controlled trial","volume":"113","author":"Petrakis","year":"2018","journal-title":"Addiction"},{"key":"10.1016\/j.neubiorev.2022.104910_bib43","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jsat.2018.08.015","article-title":"Tobacco use during a clinical trial of mecamylamine for alcohol dependence: medication effects on smoking and associations with reductions in drinking","volume":"94","author":"Roberts","year":"2018","journal-title":"J. Subst. Abus. Treat."},{"issue":"Pt 3","key":"10.1016\/j.neubiorev.2022.104910_bib44","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1093\/brain\/123.3.425","article-title":"Tourette syndrome, associated conditions and the complexities of treatment","volume":"123","author":"Robertson","year":"2000","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.neubiorev.2022.104910_bib45","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/BF03033174","article-title":"Effects of Sertoli cell transplants in a 3-nitropropionic acid model of early Huntington's disease: a preliminary study","volume":"5","author":"Rodriguez","year":"2003","journal-title":"Neurotox. Res."},{"issue":"9\u201310","key":"10.1016\/j.neubiorev.2022.104910_bib46","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1177\/0963689719854354","article-title":"A Hallmark clinical study of cord blood therapy in adults with ischemic stroke","volume":"28","author":"Sanberg","year":"2019","journal-title":"Cell Transpl."},{"issue":"1","key":"10.1016\/j.neubiorev.2022.104910_bib47","first-page":"87","article-title":"Automated measurement of multivariate locomotor behavior in rodents","volume":"7","author":"Sanberg","year":"1985","journal-title":"Neurobehav. Toxicol. Teratol."},{"issue":"3","key":"10.1016\/j.neubiorev.2022.104910_bib48","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/0091-3057(87)90369-8","article-title":"Digiscan activity: automated measurement of thigmotactic and stereotypic behavior in rats","volume":"27","author":"Sanberg","year":"1987","journal-title":"Pharm. Biochem. Behav."},{"issue":"1","key":"10.1016\/j.neubiorev.2022.104910_bib49","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1037\/0735-7044.101.1.131","article-title":"The topography of amphetamine and scopolamine-induced hyperactivity: toward an activity print","volume":"101","author":"Sanberg","year":"1987","journal-title":"Behav. Neurosci."},{"issue":"1","key":"10.1016\/j.neubiorev.2022.104910_bib50","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0753-3322(89)90186-8","article-title":"Nicotine potentiates the effects of haloperidol in animals and in patients with Tourette syndrome","volume":"43","author":"Sanberg","year":"1989","journal-title":"Biomed. Pharmacother."},{"issue":"13","key":"10.1016\/j.neubiorev.2022.104910_bib51","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1038\/nbt1296-1692","article-title":"Testis-derived Sertoli cells survive and provide localized immunoprotection for xenografts in rat brain","volume":"14","author":"Sanberg","year":"1996","journal-title":"Nat. Biotechnol."},{"issue":"1","key":"10.1016\/j.neubiorev.2022.104910_bib52","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0163-7258(96)00199-4","article-title":"Nicotine for the treatment of Tourette's syndrome","volume":"74","author":"Sanberg","year":"1997","journal-title":"Pharm. Ther."},{"issue":"9129","key":"10.1016\/j.neubiorev.2022.104910_bib53","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0140-6736(05)60822-7","article-title":"Treatment of Tourette's syndrome with mecamylamine","volume":"352","author":"Sanberg","year":"1998","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.neubiorev.2022.104910_bib54","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.physbeh.2012.06.023","article-title":"Translating laboratory discovery to the clinic: from nicotine and mecamylamine to Tourette's, depression, and beyond","volume":"107","author":"Sanberg","year":"2012","journal-title":"Physiol. Behav."},{"issue":"2","key":"10.1016\/j.neubiorev.2022.104910_bib55","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1006\/exnr.2000.7389","article-title":"Adult bone marrow stromal cells differentiate into neural cells in vitro","volume":"164","author":"Sanchez-Ramos","year":"2000","journal-title":"Exp. Neurol."},{"issue":"1","key":"10.1016\/j.neubiorev.2022.104910_bib56","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1006\/exnr.2001.7748","article-title":"Expression of neural markers in human umbilical cord blood","volume":"171","author":"Sanchez-Ramos","year":"2001","journal-title":"Exp. Neurol."},{"issue":"1 Suppl.","key":"10.1016\/j.neubiorev.2022.104910_bib57","first-page":"S63","article-title":"Functional recovery after complete contusion injury to the spinal cord and transplantation of human neuroteratocarcinoma neurons in rats","volume":"97","author":"Saporta","year":"2002","journal-title":"J. Neurosurg."},{"issue":"3","key":"10.1016\/j.neubiorev.2022.104910_bib58","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1089\/152581603322023007","article-title":"Human umbilical cord blood stem cells infusion in spinal cord injury: engraftment and beneficial influence on behavior","volume":"12","author":"Saporta","year":"2003","journal-title":"J. Hematother. Stem Cell Res."},{"issue":"2","key":"10.1016\/j.neubiorev.2022.104910_bib59","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1471-4159.1985.tb04005.x","article-title":"In vivo regulation of [3H]acetylcholine recognition sites in brain by nicotinic cholinergic drugs","volume":"45","author":"Schwartz","year":"1985","journal-title":"J. Neurochem."},{"issue":"4","key":"10.1016\/j.neubiorev.2022.104910_bib60","doi-asserted-by":"crossref","first-page":"721","DOI":"10.3727\/096368914X685311","article-title":"Human umbilical cord blood cells induce neuroprotective change in gene expression profile in neurons after ischemia through activation of Akt pathway","volume":"24","author":"Shahaduzzaman","year":"2015","journal-title":"Cell Transpl."},{"issue":"7","key":"10.1016\/j.neubiorev.2022.104910_bib61","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1177\/0963689719836763","article-title":"Immunomodulation with human umbilical cord blood stem cells ameliorates ischemic brain injury \u2013 a brain transcriptome profiling analysis","volume":"28","author":"Shiao","year":"2019","journal-title":"Cell Transpl."},{"key":"10.1016\/j.neubiorev.2022.104910_bib62","unstructured":"Shytle, D., Sanberg, P.R., Newman, M., Silver, A.A., 2006. Inventors. Exo-S-mecamylamine formulation and use in treatment. US patent 7,101,916."},{"key":"10.1016\/j.neubiorev.2022.104910_bib63","unstructured":"Shytle, D., Sanberg, P.R., Newman, M., Silver, A.A., 2011. Inventors. Exo-S-mecamylamine formulation and use in treatment. US patent 8,026,283."},{"issue":"10","key":"10.1016\/j.neubiorev.2022.104910_bib64","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/S0006-3223(00)00945-8","article-title":"Comorbid bipolar disorder in Tourette's syndrome responds to the nicotinic receptor antagonist mecamylamine (Inversine)","volume":"48","author":"Shytle","year":"2000","journal-title":"Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.neubiorev.2022.104910_bib65","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/da.10035","article-title":"Neuronal nicotinic receptor inhibition for treating mood disorders: preliminary controlled evidence with mecamylamine","volume":"16","author":"Shytle","year":"2002","journal-title":"Depress. Anxiety"},{"issue":"7","key":"10.1016\/j.neubiorev.2022.104910_bib66","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/sj.jhh.1001416","article-title":"Mecamylamine (Inversine): an old antihypertensive with new research directions","volume":"16","author":"Shytle","year":"2002","journal-title":"J. Hum. Hypertens."},{"key":"10.1016\/j.neubiorev.2022.104910_bib67","unstructured":"Shytle, R.D., Sanberg, P.R., Newman, M., Silver, A.A., 2004. Inventors. Exo-S-mecamylamine Formulation and Use in Treatment. US patent 6,734,215."},{"issue":"12","key":"10.1016\/j.neubiorev.2022.104910_bib68","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1097\/00004583-199612000-00015","article-title":"Case study: long-term potentiation of neuroleptics with transdermal nicotine in Tourette's syndrome","volume":"35","author":"Silver","year":"1996","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"issue":"2","key":"10.1016\/j.neubiorev.2022.104910_bib69","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1089\/cap.2000.10.59","article-title":"Mecamylamine in Tourette's syndrome: a two-year retrospective case study","volume":"10","author":"Silver","year":"2000","journal-title":"J. Child Adolesc. Psychopharmacol."},{"issue":"9","key":"10.1016\/j.neubiorev.2022.104910_bib70","doi-asserted-by":"crossref","first-page":"707","DOI":"10.4088\/JCP.v62n0908","article-title":"Transdermal nicotine and haloperidol in Tourette's disorder: a double-blind placebo-controlled study","volume":"62","author":"Silver","year":"2001","journal-title":"J. Clin. Psychiatry"},{"issue":"9","key":"10.1016\/j.neubiorev.2022.104910_bib71","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1097\/00004583-200109000-00020","article-title":"Multicenter, double-blind, placebo-controlled study of mecamylamine monotherapy for Tourette's disorder","volume":"40","author":"Silver","year":"2001","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"issue":"22","key":"10.1016\/j.neubiorev.2022.104910_bib72","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1056\/NEJM199211263272201","article-title":"Unilateral transplantation of human fetal mesencephalic tissue into the caudate nucleus of patients with Parkinson's disease","volume":"327","author":"Spencer","year":"1992","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neubiorev.2022.104910_bib73","series-title":"Oral History of Neuropsychopharmacology: The First Fifty Years, Peer Interviews: Volume Three: Neuropharmacology: ACNP","first-page":"435","article-title":"Paul Ronald Sanberg interviewed by Matthew J. Wayner","author":"Sulser","year":"2011"},{"issue":"1","key":"10.1016\/j.neubiorev.2022.104910_bib74","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/JCP.0000000000000269","article-title":"Safety and tolerability of dexmecamylamine (TC-5214) adjunct to ongoing antidepressant therapy in patients with major depressive disorder and an inadequate response to antidepressant therapy: results of a long-term study","volume":"35","author":"Tummala","year":"2015","journal-title":"J. Clin. Psychopharmacol."},{"issue":"10","key":"10.1016\/j.neubiorev.2022.104910_bib75","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1161\/01.STR.0000141681.06735.9b","article-title":"Infusion of human umbilical cord blood cells in a rat model of stroke dose-dependently rescues behavioral deficits and reduces infarct volume","volume":"35","author":"Vendrame","year":"2004","journal-title":"Stroke"},{"issue":"4","key":"10.1016\/j.neubiorev.2022.104910_bib76","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.euroneuro.2013.12.008","article-title":"Efficacy and tolerability of flexibly-dosed adjunct TC-5214 (dexmecamylamine) in patients with major depressive disorder and inadequate response to prior antidepressant","volume":"24","author":"Vieta","year":"2014","journal-title":"Eur. Neuropsychopharmacol.: J. Eur. Coll. Neuropsychopharmacol."},{"issue":"22","key":"10.1016\/j.neubiorev.2022.104910_bib77","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1056\/NEJM199211263272203","article-title":"Bilateral fetal mesencephalic grafting in two patients with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)","volume":"327","author":"Widner","year":"1992","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.neubiorev.2022.104910_bib78","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0361-9230(01)00625-6","article-title":"hNT neurons delay onset of motor deficits in a model of amyotrophic lateral sclerosis","volume":"56","author":"Willing","year":"2001","journal-title":"Brain Res. Bull."},{"issue":"3","key":"10.1016\/j.neubiorev.2022.104910_bib79","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/jnr.10659","article-title":"Intravenous versus intrastriatal cord blood administration in a rodent model of stroke","volume":"73","author":"Willing","year":"2003","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.neubiorev.2022.104910_bib80","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3389\/fnins.2016.00132","article-title":"Animal models of Tourette syndrome-from proliferation to standardization","volume":"10","author":"Yael","year":"2016","journal-title":"Front. Neurosci."},{"issue":"4","key":"10.1016\/j.neubiorev.2022.104910_bib81","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/S0149-2918(01)80059-X","article-title":"Mecamylamine: new therapeutic uses and toxicity\/risk profile","volume":"23","author":"Young","year":"2001","journal-title":"Clin. Ther."},{"issue":"12","key":"10.1016\/j.neubiorev.2022.104910_bib82","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1080\/14622200802443569","article-title":"Tobacco use and cessation in psychiatric disorders: National Institute of Mental Health report","volume":"10","author":"Ziedonis","year":"2008","journal-title":"Nicotine Tob. Res."}],"container-title":["Neuroscience &amp; Biobehavioral Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149763422003992?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149763422003992?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T10:29:23Z","timestamp":1758968963000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149763422003992"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":82,"alternative-id":["S0149763422003992"],"URL":"https:\/\/doi.org\/10.1016\/j.neubiorev.2022.104910","relation":{},"ISSN":["0149-7634"],"issn-type":[{"type":"print","value":"0149-7634"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The boundlessness of behavioral neuroscience: A look across 30 years","name":"articletitle","label":"Article Title"},{"value":"Neuroscience & Biobehavioral Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neubiorev.2022.104910","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104910"}}